Suppr超能文献

偏头痛患者血清二胺氧化酶(DAO)活性水平降低。

Low serum diamine oxidase (DAO) activity levels in patients with migraine.

机构信息

Department of Neurology, Hospital General de Catalunya, C/ Pere i Pons 1, 08915, Sant Cugat del Vallès, Spain.

Department of Basic Sciences, Universitat Internacional de Catalunya, C/ Pere i Pons 1, 08915, Sant Cugat del Vallès, Spain.

出版信息

J Physiol Biochem. 2018 Feb;74(1):93-99. doi: 10.1007/s13105-017-0571-3. Epub 2017 Jun 17.

Abstract

Histamine intolerance is a disorder in the homeostasis of histamine due to a reduced intestinal degradation of this amine, mainly caused by a deficiency in the enzyme diamine oxidase (DAO). Among the several multi-faced symptoms associated with histamine intolerance, headache is one of the most recognized and disabling consequences. The aim of this study was to determine the prevalence of DAO deficiency in patients with a confirmed migraine diagnosis according to the current International Headache Society (IHS) and in non-migraine subjects. DAO activity was assessed in a total of 198 volunteers recruited at the Headache Unit of the Hospital General de Catalunya, 137 in the migraine group and 61 as a control group. DAO enzyme activity in blood samples was determined by ELISA test. Values below 80 HDU/ml (Histamine Degrading Unit/ml) were considered as DAO deficient. Mean value of DAO activity from migraine population (64.5 ± 33.5 HDU/ml) was significantly lower (p < 0.0001) than that obtained from healthy volunteers (91.9 ± 44.3 HDU/ml). DAO deficiency was more prevalent in migraine patients than in the control group. A high incidence rate of DAO deficiency (87%) was observed in the group of patients with migraine. On the other hand, 44% of non-migranous subjects had levels of DAO activity lower than 80 HDU/ml. Despite the multifactorial aetiology of migraine, these results seem to indicate that this enzymatic deficit could be related to the onset of migraine.

摘要

组织胺不耐受是由于肠道对这种胺的降解减少,主要是由于二胺氧化酶(DAO)缺乏,导致组织胺内稳态紊乱。在与组织胺不耐受相关的多种多面症状中,头痛是最被认可和致残的后果之一。本研究旨在根据当前的国际头痛协会(IHS)确定在确诊偏头痛诊断的患者中 DAO 缺乏的患病率,以及在非偏头痛患者中的患病率。共招募了 198 名志愿者在加泰罗尼亚综合医院头痛科进行研究,其中 137 名在偏头痛组,61 名作为对照组。通过 ELISA 试验测定血液样本中的 DAO 活性。低于 80 HDU/ml(组织胺降解单位/ml)的值被认为是 DAO 缺乏。偏头痛患者组的 DAO 活性平均值(64.5±33.5 HDU/ml)明显低于健康志愿者组(91.9±44.3 HDU/ml)(p<0.0001)。偏头痛患者中 DAO 缺乏症更为普遍。偏头痛患者组的 DAO 缺乏发生率很高(87%)。另一方面,44%的非偏头痛患者的 DAO 活性水平低于 80 HDU/ml。尽管偏头痛的病因复杂,但这些结果似乎表明这种酶缺乏可能与偏头痛的发作有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验